Jak inhibitor compound and pharmaceutical composition including the same
Grant
US12590088B2
Kind: B2
Mar 31, 2026
Assignee
KOREA PHARMA CO., LTD.
Inventors
Soosung Kang, Eun Sun Park, Eun Hee Park, Seung Hee Han
Abstract
The present invention relates to a JAK inhibitor compound and a pharmaceutical composition including the same. More specifically, the present invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof and a pharmaceutical composition including the same. The structure of the compound of Formula I is described in the specification. The compound of the present invention can exhibit therapeutic effects on a variety of diseases, for example, inflammatory diseases, autoimmune diseases, myeloproliferative diseases, and human cancers due to its ability to regulate signal transduction at the level of JAK kinases.
CPC Classifications
C07D 471/04
A61K 31/437
A61K 31/439
A61K 31/4545
A61K 31/46
A61K 31/55
A61P 35/00
A61P 37/00
Filing Date
2020-05-27
Application No.
17613291
Claims
4